Nathan Collins BSc, PhD

Nathan Collins is responsible for research and development and leads the organization’s Centers for Cancer and Metabolism, Immunology and Infectious Diseases, and Chemical Biology located in Menlo Park, California and Harrisonburg, Virginia. The centers conduct basic and translational research in the life sciences.

Specializing at the interface between innovative, translational R&D, and commercialization, Collins has more than 20 years of experience in the biotechnology industry and has worked for more than 10 years as an executive manager. His research experience covers drug discovery from basic research through to clinical development. He is also responsible for the development of SRI’s portfolio of drug discovery and diagnostics technologies.